<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02113215</url>
  </required_header>
  <id_info>
    <org_study_id>11-318</org_study_id>
    <secondary_id>1R01AG033761-01A1</secondary_id>
    <nct_id>NCT02113215</nct_id>
  </id_info>
  <brief_title>Very Low Density Lipoprotein Turnover in Young and Elderly Individuals</brief_title>
  <official_title>Very Low Density Lipoprotein Turnover in Young and Elderly Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrahepatic and intramyocellular lipid concentrations are elevated in elderly individuals&#xD;
      relative to young people, despite no significant difference in fasting plasma TAG&#xD;
      concentrations. Our general hypothesis is that the increase in intrahepatic fat with age&#xD;
      results from reduced VLDL turnover, and therefore elderly individuals in this study will&#xD;
      display lower VLDL turnover rates than young individuals. The aims of this study are a) to&#xD;
      compare VLDL turnover in young and elderly individuals, and b) to compare a bolus method and&#xD;
      a constant infusion method of assessing VLDL turnover.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have shown an association between hypertriacylglycerolaemia and coronary&#xD;
      artery disease. Additionally, ectopic fat distribution, in particular, deposition of excess&#xD;
      lipid within the liver and skeletal muscle, has been shown to correlate negatively with&#xD;
      insulin sensitivity, thus presenting a metabolic milieu in which risk of developing type 2&#xD;
      diabetes is elevated. Previous research from our group has shown that the triacylglycerol&#xD;
      (TAG) concentration within the liver, and within skeletal muscle fibres IMCLs&#xD;
      (intramyocellular lipids), is increased in elderly individuals compared with young people.&#xD;
      The elevation of lipids in these particular tissues for the elderly group was observed&#xD;
      despite no statistically significant difference in fasting plasma TAG concentration. As the&#xD;
      plasma TAG concentration during the postabsorptive state is largely determined by the&#xD;
      production and clearance rates of very low density lipoprotein triacylglycerol (VLDL-TAG),&#xD;
      and increased liver fat content has been shown to drive production of large VLDL particles,&#xD;
      it is important to gain an understanding of whether VLDL synthesis and breakdown differs&#xD;
      between young and elderly individuals. Such new knowledge may offer an insight into why&#xD;
      tissue lipids are elevated in the elderly. At present, no data exist in the literature&#xD;
      describing VLDL turnover in elderly people. We hypothesise that very low density lipoprotein&#xD;
      turnover will be reduced in elderly individuals compared with young people. The aims of this&#xD;
      study are a) to determine whether fractional synthesis and breakdown rates of both the&#xD;
      protein and lipid parts of the VLDL are different between young and elderly individuals, and&#xD;
      b) to determine whether VLDL turnover values appear different when calculated using a&#xD;
      constant infusion tracer method as compared with a bolus tracer method. Eight young men,&#xD;
      eight young women, eight elderly men and eight elderly women will each participate in an&#xD;
      8-hour infusion study. Stable isotopes of glycerol, amino acids and fatty acids will be&#xD;
      infused, and blood samples will be drawn in intervals during the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI left UTMB&#xD;
  </why_stopped>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Very Low Density Lipoprotein (VLDL) Turnover</measure>
    <time_frame>9-hours</time_frame>
    <description>Turnover rates of VLDL-triglycerides and VLDL-ApoB (apolipoprotein B)-100, including synthesis and breakdown rates, measured during a 9-hour infusion trial.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Young Males</arm_group_label>
    <description>Males, age 18-35 years. 9-hour Stable isotope infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Females</arm_group_label>
    <description>Females, age 18-35 years. 9-hour Stable isotope infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Males</arm_group_label>
    <description>Males, age 60-75. 9-hour Stable isotope infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Females</arm_group_label>
    <description>Females, age 60-75. 9-hour Stable isotope infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stable Isotope Infusion</intervention_name>
    <description>9-hour infusion of stable isotope tracers</description>
    <arm_group_label>Older Females</arm_group_label>
    <arm_group_label>Older Males</arm_group_label>
    <arm_group_label>Young Females</arm_group_label>
    <arm_group_label>Young Males</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and muscle biopsies will be collected.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy individuals from the Galveston area.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 to 35 years, or 60 to 75 years.&#xD;
&#xD;
          -  Body mass index ≤ 27 kg•m2&#xD;
&#xD;
          -  Ability to sign informed consent.&#xD;
&#xD;
          -  Score of ≥26 for Mini-Mental State Exam&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetics (plasma glucose concentration &gt;200 mg/dl at 2 hr after oral intake of 75 g&#xD;
             glucose).&#xD;
&#xD;
          -  Fasting plasma triacylglycerol concentration above 500 mg/dl&#xD;
&#xD;
          -  Kidney disease.&#xD;
&#xD;
          -  Liver disease.&#xD;
&#xD;
          -  Bleeding disorders.&#xD;
&#xD;
          -  Anaemia (Hb &lt; 13 g/dl in males or &lt; 12 g/dl in females).&#xD;
&#xD;
          -  Endocrine disease (with the exception of well-regulated hypothyroidism).&#xD;
&#xD;
          -  Positive hepatitis or HIV screens.&#xD;
&#xD;
          -  Alcohol (CAGE questionnaire; abnormal liver enzyme values) or drug abuse&#xD;
             (amphetamines, cocaine, opioids, marijuana).&#xD;
&#xD;
          -  Lipid altering agents.&#xD;
&#xD;
          -  Score of &lt;26 for Mini-Mental State Exam&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabet Borsheim, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Medical Branch, Dept of Surgery</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>April 10, 2014</study_first_submitted>
  <study_first_submitted_qc>April 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2014</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aging</keyword>
  <keyword>lipid metabolism</keyword>
  <keyword>very low density lipoproteins</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

